- Home
- FOLD vs ASB Comparison
FOLD vs ASB Comparison
Compare FOLD & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- ASB
- Stock Information
- Founded
- FOLD 2002
- ASB 1861
- Country
- FOLD United States
- ASB United States
- Employees
- FOLD N/A
- ASB N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- ASB Major Banks
- Sector
- FOLD Health Care
- ASB Finance
- Exchange
- FOLD Nasdaq
- ASB Nasdaq
- Market Cap
- FOLD 2.9B
- ASB 3.4B
- IPO Year
- FOLD 2007
- ASB N/A
- Fundamental
- Price
- FOLD $6.12
- ASB $25.55
- Analyst Decision
- FOLD Buy
- ASB Hold
- Analyst Count
- FOLD 10
- ASB 10
- Target Price
- FOLD $16.22
- ASB $27.40
- AVG Volume (30 Days)
- FOLD 5.5M
- ASB 1.4M
- Earning Date
- FOLD 08-07-2025
- ASB 07-24-2025
- Dividend Yield
- FOLD N/A
- ASB 3.55%
- EPS Growth
- FOLD N/A
- ASB N/A
- EPS
- FOLD N/A
- ASB 0.83
- Revenue
- FOLD $543,141,000.00
- ASB $985,729,000.00
- Revenue This Year
- FOLD $19.87
- ASB $54.48
- Revenue Next Year
- FOLD $23.15
- ASB $5.84
- P/E Ratio
- FOLD N/A
- ASB $30.87
- Revenue Growth
- FOLD 28.25
- ASB N/A
- 52 Week Low
- FOLD $5.51
- ASB $18.32
- 52 Week High
- FOLD $12.65
- ASB $28.18
- Technical
- Relative Strength Index (RSI)
- FOLD 51.42
- ASB 64.14
- Support Level
- FOLD $5.66
- ASB $25.46
- Resistance Level
- FOLD $6.45
- ASB $26.21
- Average True Range (ATR)
- FOLD 0.21
- ASB 0.55
- MACD
- FOLD 0.07
- ASB 0.12
- Stochastic Oscillator
- FOLD 64.89
- ASB 79.97
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.